Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BCEL Atreca Inc

-0.0188 (-7.15%)
After Hours
Last Updated: 16:54:59
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Atreca Inc BCEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0188 -7.15% 0.244 16:54:59
Open Price Low Price High Price Close Price Prev Close
0.2699 0.235 0.2699 0.241 0.2628
more quote information »

Recent News

Date Time Source Heading
12/08/20236:10IHNWFeaturedFREEDOM HOLDINGS (FHLD) SHAREHOLDER UPDATE; Freedom, Holdings Inc symbol: FHLD 15C-211 nears final approval from FINRA
11/14/202316:30GLOBEAtreca Reports Third Quarter 2023 Financial Results and..
9/27/202319:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/21/202308:01EDGAR2Form 8-K - Current report
9/21/202308:00GLOBEAtreca Announces Agreement to Terminate Lease and Departure..
9/14/202316:01EDGAR2Form 8-K - Current report
8/18/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
8/16/202317:20EDGAR2Form S-3/A - Registration statement under Securities Act of..
8/10/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:05EDGAR2Form 8-K - Current report
8/10/202316:05GLOBEAtreca Reports Second Quarter 2023 Financial Results and..
8/04/202318:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/04/202318:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/19/202309:18EDGAR2Form S-3 - Registration statement under Securities Act of..
6/05/202308:00GLOBEAtreca Presents Data from Ongoing Phase 1b Study of ATRC-101..
5/10/202316:05GLOBEAtreca Reports First Quarter 2023 Financial Results and..
4/26/202316:05GLOBEAtreca Announces Oral Presentation of ATRC-101 Phase 1b..
4/13/202308:00GLOBEAtreca to Participate in the Canaccord Genuity Horizons in..
3/29/202316:05GLOBEAtreca Reports Fourth Quarter and Full-Year 2022 Financial..
3/23/202317:00GLOBEAtreca to Host Fourth Quarter and Year End 2022 Conference..
3/01/202308:00GLOBEAtreca to Participate at Cowen’s 43rd Annual Health Care..
2/06/202308:00GLOBEAtreca and Xencor to Develop T Cell Engaging Bispecific..
1/09/202308:30GLOBEAtreca Appoints Philippe Bishop, MD as Chief Medical Officer

Your Recent History

Delayed Upgrade Clock